<<

Список литературы

1. Каратеев Д.Е. Основная тенденция и вариабельность эволюции ревматоидного артрита: результаты многолетнего наблюдения. / Каратеев Д.Е. // Научно-практическая ревматология. - 2004.

- №1. - C.8-14.

2. Национальное руководство. Ревматология. / Под ред. Насонова Е.Л, Насоновой В.А. - М. 2008. -720 с.

3. Gabriel S.E. The epidemiology of rheumatoid arthritis./ Gabriel S.E. // Rheum Dis clin North Am - 2001. - Vol. 27(2). - P. 269-281.

4. Tobon G.J. The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis. / Tobon G.J., Youinou P., Saraux A// J Autoimmun. - 2010.

- Vol.35(1). - P.10-14.

5. Gonzalez A. The widening mortality gap between rheumatoid arthritis patients and the general population. / Gonzalez A., Maradit-Kremers H., Crowson C.S. et.al.// Arthritis Rheum. - 2007. -Vol.56(11). - P.3583-3587.

6. Kitas G.D. Tackling ischaemic heart disease in rheumatoid arthritis. / Kitas G.D., Erb N // Rheumatology (Oxford). - 2003. - Vol.42(5). - P.607-613.

7. van Halm V.P. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. / van Halm V.P., Peters M.J., Voskuyl A.E., Boers M., Lems W.F., Visser M., Stehouwer C.D., Spijkerman A.M., Dekker J.M., Nijpels G., Heine R.J., Bouter L.M., Smulders Y.M., Dijkmans B.A., Nurmohamed M.T. // Ann Rheum Dis. - 2009. -Vol.68(9). - P.1395-400.

8. Carmona L. Rheumatoid arthritis. / Carmona L., Cross M., Williams B., Lassere M., March L.// Best Pract Res Clin Rheumatol. - 2010. -Vol.24(6). - P.733-745.

9. Symmons D.P. Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well./ Symmons D.P., Jones M.A., Scott D.L., Prior P. // J Rheumatol. - 1998. - Vol.25(6). -P.1072-1077.

10. Koivuniemi R. Causes of death in patients with rheumatoid arthritis autopsied during a 40-year period.

/ Koivuniemi R., Paimela L., Suomalainen R., Piirainen H., Karesoja M., Helve T., Leirisalo-Repo M. // Rheumatol Int. - 2008. -Vol.28(12). - P.1245-1252.

11. Gabriel S.E. Heart disease and rheumatoid arthritis:understanding the risks./ Gabriel S.E. // Ann Rheum Dis - 2010. -Vol.69(Suppl I). - P.61-64.

12. Douglas K.M.J. Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. / Douglas K.M.J., Pace A.V., Treharne G.J., Saratzis A., Nightingale P., Erb N., Banks M.J., Kitas G.D.// Ann Rheum Dis. - 2006. -Vol.65. - P.348-353.

13. Naranjo A. Cardiovascular disease in patients with rheumatoid arthritis:results from the QUEST-RA study. / Naranjo A., Sokka T., Descalzo M.A., Calvo-Alen J. et.al. // Arthritis Res Ther. - 2008. - Vol. 10(2). - P.30.

14. Dhawan S.S. Rheumatoid arthritis and cardiovascular disease. / Dhawan S.S., Quyyumi A.A. // Curr Atheroscler Rep. - 2008. -Vol. 10(2). -P. 128-133.

15. Boyer J.F. Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis./Boyer J.F., Gourraud P.A., Cantagrel A., Davignon J.L., Constantin A. // Joint Bone Spine. - 2010. - Sep 16.

16. Насонов Е.Л. Кардиоваскулярные проблемы ревматологии. / Насонов Е.Л., Попкова Т.В.// Науч.-практ.ревматология. - 2004. - №4. - С.4-9.

17. Попкова Т.В Сердечно-сосудистые заболевания при ревматоидном артрите. / Попкова Т.В., Хелковская А.Н., Мач Э.С, Александрова Е.Н.,

Новиков А.А., Новикова Д.С., Насонов Е.Л. // Терапевтический архив . -2007.

- №5. - С.9-14.

18. Мясоедова Е.Е. Структурно-функциональные особенности миокарда левого желудочка и эндотелиальная дисфункция при ревматоидном артрите в зависимости от наличия артериальной гипертонии. / Мясоедова Е.Е., Мясоедова С.Е., Омельяненко М.Г., Обжерина С.В. // Научно-практическая ревматология. - 2007. - №3. - С.15-20.

19. Никитина Н.М. Определение риска развития сердечно-сосудистых заболеваний у больных ревматоидным артритом. /Никитина Н.М, Ребров А.П.

// Терапевтический архив. - 2009. - №6. - С.29-34.

20. del Rincon I.D. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. /del Rincon I.D., Williams K., Stern M.P., Freeman G.L., Escalante A. // Arthritis Rheum. - 2001.

- Vol.44(12). - P.2737-2745.

21. Gonzalez A. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? / Gonzalez A., Maradit-Kremers H., Crowson C.S., Ballman K.V., Roger V.L., Jacobsen S.J., O'Fallon W.M., Gabriel S.E.// Ann Rheum Dis.

- 2008. -Vol.67(1). - P.64-69.

22. Sattar N. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. / Sattar N., McCarey D.W., Capell H., McInnes I.B. // Circulation. - 2003 Dec. - Vol.108(24). - P.2957-2963.

23. Solomon D.H. Patterns of cardiovascular risk in rheumatoid arthritis. / Solomon D.H., Goodson N.J., Katz J.N., Weinblatt M.E., Avorn J, Setoguchi S., Canning C., Schneeweiss S. // Ann Rheum Dis. - 2006. -Vol.65(12). - P. 1608-1612.

24. Насонов Е.Л. Поражение сосудов при ревматических заболеваниях: связь с атеросклерозом. Васкулиты и васкулопатии. / Насонов Е.Л., Алекберова З.С., Карпов Ю.А., Попоква Т.В., Фомичева О.А, Баранов А.А., Шилкина Н.П. - Ярославль: Верхняя Волга, 1999. - 574-592 c.

25. Ross R. Atherosclerosis - an inflammatory disease. / Ross R. // N Engl J Med - 1999. -Vol.340. - P.115-126.

26. Rho Y.H. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. / Rho Y.H., Chung C.P., Oeser A., Solus J., Asanuma Y., Sokka T., Pincus T., Raggi P., Gebretsadik T., shintani A., Stein C.M. // Arthritis Rheum. - 2009. -Vol. 61(11). - P.1580-1585.

27. Hannawi S. Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. / Hannawi S., Haluska B., Marwick T.H., Thomas R. // Arthritis Res Ther.

- 2007. - Vol.9(6). - P.116.

28. del Rincon I.D. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patient and healthy subjects. del Rincon I.D., Williams K., Stern M.P., Freeman G.L. et.al. / Arthritis Rheum // - 2003. -Vol.48(7). - P.1833-1840.

29. Насонов Е.Л. Проблема атеротромбоза в ревматологии. / Насонов Е.Л. // Вестн РАМН. - 2003. - №7. - C.6-10.

30. Попкова Т.В. Атеросклероз при ревматических заболеваниях. Ревматология. Клинические рекомендации. / Попкова Т.В., Новиков Д.С., Насонов Е.Л.; под ред. Е.Л. Насонова. М. - М: ГЭОТАР-Медиа, 2010. - 678­702c.

31. Shoenfeld Y. Accelerated atherosclerosis in autoimmune rheumatic diseases. / Shoenfeld Y., Gerli R., Doria A., Matsuura E., Cerinic M.M., Ronda N., Jara L.J.,

Abu-Shakra M., Meroni P.L., Sherer Y. // Circulation. - 2005. -Vol.112(21).

- P.3337-3347.

32. Roman M.J. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. / Roman M.J., Moeller E., Davis A., Paget S.A., Crow M.K., Lockshin M.D., Sammaritano L., Devereux R.B., Schwartz J.E., Levine D.M., Salmon J.E. // Ann Intern Med. - 2006. - Vol. 144(4). - P.249-256.

33. Cavagna L. Atherosclerosis and rheumatoid arthritis: more than a simple association. / Cavagna L., Caporali R., Boffini N., Cagnotto G, Inverardi F., Grosso V. // Mediators Inflamm. - 2012. - Sep 13.

34. Van Sijl A.M. Different type of carotid arterial wall remodeling in rheumatoid arthritis compared with healthy subjects: a case-control study. /Van Sijl A.M., Van Den Hurk K., Peters M.J., Van Halm V.P., Nijpels G., Stehouwer C.D., Smulders Y.V., Voskuyl A.E., Dekker J.M., Nurmohamed M.T. // J Rheumatol. - 2012. Vol.39(12). - P.2261-2266.

35. Ridker P.M. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. / Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. // N Engl J Med - 2002. -Vol.347(20).

- P.1557-1565.

36. Danesh J C-reactive protein in healthy and in sick populations. / Danesh J., Pepys M.B. // Eur Heart J. - 2000. -Vol.21(19). - P. 1564-1565.

37. Cao J.J. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. / Cao J.J., Thach C., Manolio T.A., Psaty B.M., Kuller L.H., Chaves P.H., Polak J.F., Sutton-Tyrrell K., Herrington D.M., Price T.R., Cushman M. // Circulation. - 2003. -Vol.108(2).

- P.166-170.

38. Giles J.T. Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis. / Giles J.T., Post W.S., Blumenthal R.S., Polak J., Petri M., Gelber A.C., Szklo M., Bathon J.M. // Arthritis Rheum. - 2011. -Vol. 63(11). -P.3216-3225.

39. Шостак Н.А Ревматоидная болезнь сердца: клинико-интсрументальные параллели и новые перспективы лечения. / Шостак Н.А., Махнырь Е.Ф., Голоухова Л.М. // Фарматека. - 2005. - №8. - C.50-53.

40. Красносельский М.Я. Тканевая допплерография миокарда в диагностике поражения миокарда у больных ревматоидным артритом. / Красносельский М.Я., Братанова М.З., Полупан А.А., Цурко В.В. // Кардиология - 2007.

- №10. - Т.47. - C.59-62.

41. Махнырь Е.Ф. Клинико-интсрументальная диагностика поражения сердца у больных ревматоидным артритом: автореферат диссертации. .. .канд.мед.наук / Махнырь Е.Ф. - М, 2004.

42. Колотова Г.Б. Структурно-функциональное состояние левых отделов сердца у больных ревматоидным артритом. /Колотова Г.Б., Завалина Д.Е., Гришина И.Ф. //Научно-практическая ревматология - 2007. - №1. - C.22-27.

43. Аничков Д.А. Ревматоидный артрит. Руководство по неишемической кардиологии/ Аничков Д.А., Шостак Н.А.; под ред. Н.А. Шостак. - Москва: ГЭОТАР-Медиа, 2009. - 48-63 с.

44. Killinger L.C. Case 5/2001 - Heart failure and insufficiency of the aortic and mitral valves in a 68-year-old woman with rheumatoid arthritis. Clinicopathologic session. / Killinger L.C., Gutierrez P.S. // Arq Bras Cardiol. - 2001. -Vol.77(4).

- P.369-376.

45. Rexhepaj N. Left and right ventricular diastolic functions in patients with rheumatoid arthritis without clinically evident cardiovascular disease. / Rexhepaj N., Bajraktari G., Berisha I., Beqiri A., Shatri F., Hima F., Elezi S., Ndrepepa G. // Int J Clin Pract. - 2006. -Vol.60(6). - P.683-688.

46. Levy D. Prognostic implications of echocardiographically determined left vetricular mass in the Framingham Heart Study. / Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. // N Engl J Med. - 1990. -Vol. 322(22).

- P.1561-1566.

47. Bikkina M. Left ventricular mass and risk of stroke in an eldery cohort./ Bikkina M., Levy D., Evans J.C., Larson M.G., Benjamin E.J., Wolf P.A., Castelli W.P. // The Framingham Heart Study. JAMA. - 1994. -Vol.272(1). - P.33-36.

48. Novo S. Increased prevalence of cardiac arrhythmias and transient episodes of myocardial ishemia in hypertensives with left ventricular hypertrophy but without clinical history of coronary heart disease. / Novo S., Barbagallo M., Abrignani M.G., Nardi E., Di Maria G.U., Longo B., Mistretta A., Strano A. // Am J Hypertens. - 1997. -Vol.10 (8). - P.843-851.

49. Haider A.W. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. / Haider A.W., Larson M.G., Benjamin E.J., Levy D. // J Am Coll Cardiol. - 1998. - Vol.32(5) - P. 1454-1459

50. Rudominer R.L. Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. / Rudominer R.L., Roman M.J., Devereux R.B., Paget S.A., Schwartz J.E., Lockshin M.D., Crow M.K., Sammaritano L., Levine D.M., Salmon J.E. // Arthritis Rheum. - 2009.

- Vol.60(1). - P.22-29.

51. Vizzardi E. Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: comment on the article by Rudominer et al.. / Vizzardi E., Cavazzana I.,

Ceribelli A., Tincani A., Dei Cas L., Franceschini F. // Arthritis Rheum. - 2009. -Vol. 60(9). - P.2852-2853.

52. Giles J.T. Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. / Giles J.T., Malayeri A.A., Fernandes V., Post W., Blumenthal R.S., Bluemke D., Vogel-Claussen J., Szklo M., Petri M., Gelber A.C., Brumback L., Lima J., Bathon J.M. // Arthritis Rheum - 2010. -Vol.62(4). - P.940-951.

53. Guilleminault C. Obstructive sleep apnea: electromyographic and fiberoptic studies / Guilleminault C., Hill M.W., Simmons F.B., Dement W.C.. // Exp Neurol.

- 1978. -Vol.62(1). - P.48-67.

54. Phillips C.L. Hypertension and obstructive sleep apnea. / Phillips C.L., O'Driscoll D.M.// Nat Sci Sleep. - 2013. -Vol.5. - P. 43-52.

55. Goncalves S.C. Obstructive sleep apnea and resistant hypertension: a case­control study. / Goncalves S.C., Martinez D., Gus M., de Abreu-Silva E.O., Bertoluci C., Dutra I., Branchi T., Moreira L.B., Fuchs S.C., de Oliveira A.C., Fuchs F.D. // Chest. - 2007. - Vol.132(6). - P.1858-1862.

56. Schulz R. Andreas S., working group Kreislauf und Schlaf of the German Sleep Society (DGSM). Sleep apnoea in heart failure. / Schulz R., Blau A., Borgel J., Duchna H.W., Fietze I., Koper I., Prenzel R., Schadlich S., Schmitt J., Tasci S. // Eur Respir J. - 2007. - Vol.29(6). - P.1201-1205.

57. Durgan D.J. Cerebrovascular consequences of obstructive sleep apnea. /Durgan D.J., Bryan R.M.Jr.// J Am Heart Assoc. - 2012. - Aug 24.

58. Shimizu M. Obstructive sleep apnea in RA patients and effect of CPAP on RA activity. / Shimizu M., Tachibana N., Hagasaka Y., Goto M. // Arthritis Rheum.

- 2003. - Vol.48. - P.114.

59. Holman A.J. Prevalence of obstructive sleep apnea (OSA) in men with inflammatory arthritis. / Holman A.J., De Paso W.J. // Arthritis Rheum - 2004. -Vol.50. - P.385.

60. Franklin K.A. Sleep apnoea and nocturnal angina. / Franklin K.A., Nilsson J.B., Sahlin C., Naslund U. // Lancet. - 1995. - Vol.345(8957). - P.1085-1087.

61. Holman A.J. Considering cardiovascular mortality in patients with rheumatoid arthritis from different perspective:a role for autonomic dysregulation and obstructive sleep apnea. / Holman A.J. // J Rheumatol. - 2007. - Vol.34(4).

- P. 671-673.

62. Sleep Apnea and Cardiovascular Disease EXPERT CONSENSUS DOCUMENT. // J Am Coll Cardiol. - 2008. - Vol.52. - P.686-717.

63. Ерошина В.А. Диагностика и лечение храпа и обструктивного апноэ сна/ Ерошина В.А., Бузунов Р.В. - М.: У-Фактория, 2003. — 48 с.

64. Caples S.M. Influence of cardiac function and failure on sleep-disordered breathing: evidence for a causative role / Caples S.M., Wolk R., Somers V.K. // J Appl Physiol. - 2005. - Vol.99(6). - P.2433-2439.

65. Gottlieb D.J. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. / Gottlieb D.J., Yenokyan G., Newman A.B., O'Connor G.T., Punjabi N.M., Quan S.F., Redline S., Resnick H.E., Tong E.K., Diener-West M., Shahar E. // Circulation. - 2010.

- Vol.122(4). - P. 352-360.

66. Gozal D. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. / Gozal D., Kheirandish-Gozal L. // Am J Respir Crit Care Med. - 2008. - Vol.177(4). - P.369-375.

67. Chan K.H. Obstructive sleep aonea:novel trigger and potential therapeutic target for cardiac arrhythmias. / Chan K.H., Wilcox I. // Expert Rev Cardiovasc Ther. - 2010. - Vol.8(7). - P.981-994.

68. Shamsuzzaman A.S. Obstructive sleep apnea: implications for cardiac and vascular disease. / Shamsuzzaman A.S., Gersh B.J., Somers V.K. // JAMA. - 2003.

- Vol.290(14). - P.1906-1914.

69. Parish J.M. Obstructive sleep apnea and cardiovascular disease. / Parish J.M., Somers V.K. // Mayo Clin Proc. - 2004. - Vol.79. - P. 1036-1046.

70. Henskens L.H. Subjective sleep disturbance increases the nocturnal blood pressure level and attenuates the correlation with target-organ damage. / Henskens L.H., van Boxtel M.P., Kroon A.A., van Oostenbrugge R.J., Lodder J., de Leeuw P.W. // J Hypertens. - 2011. - Vol.29(2). - P.242-250.

71. Cutler M.J. Sleep apnea: from the nose to the heart. / Cutler M.J., Hamdan A.L., Hamdan M.H., Ramaswamy K., Smith M.L. // J Am Board Fam Pract. - 2002.

- Vol.15(2). - P.128-141.

72. Pelttari L.H Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing. / Pelttari L.H., Pelttari

L. H., Hietanen E.K., Salo T.T., Kataja M.J., Kantola I.M. // Am J Hypertens.

- 1998. - Vol.11. - P. 272-279.

73. Cuspidi C. Nocturnal nondipping and left ventricular hypertrophy in hypertension: an updated review. / Cuspidi C., Giudici V., Negri F., Sala C. // Expert Rev CardiovascTher. - 2010. - Vol.8(6). - P.781-792.

74. Lavie P. Sleep apnea syndrome: a possible contributing factor to resistant. / Lavie P., Hoffstein V. // Sleep. 2001. - Vol. 24(6) . - P.721-725.

75. Gami A.S. Day-night pattern of sudden death in obstructive sleep apnea. / Gami

A.S., Howard D.E., Olson E.J., Somers V.K.. // N Engl J Med. - 2005.

- Vol.352(12). - P.1206-1214.

76. Coumel P. Cardiac arrhythmias and the autonomic nervous system. / Coumel P. J // Cardiovasc Electrophysiol. - 1993. - Vol.4(3). - P.338-355.

77. Hanly P. ST-segment depression during sleep in obstructive sleep apnea. / Hanly P., Sasson Z., Zuberi N., Lunn K. // Am J Cardiol. - 1993. - Vol. 71(15).

- P.1341-1345.

78. Hirschfield G.M. C-reactive protein and cardiovascular disease: new insights from an old molecule. / Hirschfield G.M., Pepys M.B. // QJM. - 2003.

- Vol.96(11). - P.793-807.

79. Biasucci L.M. Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease. / Biasucci L.M., Liuzzo G., Colizzi C., Rizzello V. // Ital Heart J. - 2001. - Vol.2(3). - P.164-171.

80. Kasasbeh E. Inflammatory aspects of sleep apnea and their cardiovascular consequences./ Kasasbeh E., Chi D.S., Krishnaswamy G. // South Med J. - 2006. -Vol.99(1). - P.58-67.

81. Minoguchi K. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. / Minoguchi K., Yokoe T., Tazaki T., Minoguchi H., Tanaka A., Oda N., Okada S., Ohta S., Naito H., Adachi M. // Am J Respir Crit Care Med. - 2005. -Vol.172(5). - P.625-630.

82. Suzuki T. Obstructive sleep apnea and carotid-artery intima-media thickness. / Suzuki T., Nakano H., Maekawa J., Okamoto Y., Ohnishi Y., Yamauchi M., Kimura H. // Sleep. - 2004. - Vol.27(1). - P.129-133.

83. Drager L.F. Early signs of atherosclerosis in obstructive sleep apnea./ Drager L.F., Bortolotto L.A., Lorenzi M.C., Figueiredo A.C., Krieger E.M., Lorenzi-Filho G. // Am J Respir Crit Care Med. - 2005. - Vol.172(5). - P. 518-519.

84. Turmel J. Relationship between atherosclerosis and the sleep apnea syndrome: An intravascular ultrasound study. / Turmel J., Series F., Boulet L.P., Poirier P., Tardif J.C., Rodes-Cabeau J., Larose E., Bertrand O.F. // Int J Cardiol. - 2009.

- Vol.132(2). - P. 203-209.

85. Marin J.M. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. / Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. // Lancet. - 2005. - Vol.365(9464). -P.1046-1053.

86. Wang H. Influence of obstructive sleep apnea on mortality in patients with heart failure. / Wang H., Parker J.D., Newton G.E., Floras J.S., Mak S., Chiu K.L., Ruttanaumpawan P., Tomlinson G., Bradley T.D. // J Am Coll Cardiol. -2007.

- Vol.49(15). - P.1625-1631.

87. Young T. Epidemiology of obstructive sleep apnea: a population health perspective. / Young T., Peppard P.E., Gottlieb D.J. // Am J Respir Crit Care Med.

- 2002. - Vol.165(9). - P.1217-1239.

88. Bounhoure J.P. Sleep apnea syndromes and cardiovascular disease. / Bounhoure J.P., Galinier M., Didier A., Leophonte P. // Bull Acad Natl Med. - 2005.

- Vol.189(3). - P.445-459.

89. Kapur V.K. Sleep Heart Health Research Group.The relationship between

chronically disrupted sleep and healthcare use. / Kapur V.K., Redline S., Nieto F.J., Young T.B., Newman A.B., Henderson J.A. // Sleep. - 2002. - Vol.25(3).

- P.289-296.

90. Young T. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women / Young T., Evans L., Finn L., Palta

M..// Sleep. - 1997. - Vol.20(9). - P.705-706.

91. Jean-Louis G. Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. /Jean-Louis G., Zizi F., Clark L.T., Brown C.D., McFarlane S.I.// J Clin Sleep Med. - 2008. - Vol.4(3). - P.261-272.

92. Parish J.M. Relationship of metabolic syndrome and obstructive sleep apnea. / Parish J.M., Adam T., Facchiano L. // J Clin Sleep Med. - 2007. - Vol.3(5).

- P.467-472.

93. Kushida C.A. A predictive morphometric model for the obstructive sleep apnea syndrome. / Kushida C.A., Efron B., Guilleminault C. // Ann Intern Med. - 1997. - Vol.127(8 Pt 1). - P.581-587.

94. Coughlin S.R Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. / Coughlin S.R., Mawdsley L., Mugarza J.A., Calverley P.M., Wilding J.P. // Eur Heart J. - 2004. - Vol.25(9).

- P.735-741.

95. Peppard P.E. Longitudinal study of moderate weight change and sleep- disordered breathing / Peppard P.E., Young T., Palta M., Dempsey J., Skatrud J. // JAMA. - 2000. - Vol.284(23). - P.3015-3021.

96. Pincus T. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. / Pincus T., Brooks R.H., Callahan L.F. // Ann Intern Med. - 1994. - Vol.1. - P.26-34.

97. Wolfe F. The mortality of rheumatoid arthritis. / Wolfe F., Mitchell D.M., Sibley J.T., Fries J.F., Bloch D.A., Williams C.A., Spitz P.W., Haga M., Kleinheksel S.M., Cathey M.A. // Arthritis Rheum. - 1994. - Vol.37(4). -P.481-494.

98. Mutru O. Cardiovascular mortality in patients with rheumatoid arthritis. / Mutru O., Laakso M., Isomaki H., Koota K. // Cardiology. - 1989. -Vol.76(1). -P.71-77.

99. Myllykangas-Luosujrvi R. Mortality in rheumatoid arthritis. / Myllykangas- Luosujrvi R., Aho K., Isomaki H. // Semin. Arthritis Rheum. - 1995. - Vol. 25(3). -P.193-202.

100. Gerli R. Cardiovascular involvement in rheumatoid arthritis. / Gerli R., Goodson N.J. // Lupus. - 2005. - Vol.14(9). - P.679-682.

101. Bergstrom U. G. Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmo, Sweden. / Bergstrom U. G., Jacobsson L.T.H.,Turesson C. // Rheumatology. - 2009. - Vol.48. - P.1600-1605.

102. Young A. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischemic heart disease and pulmonary fibrosis. /Young A., Koduri G., Batley M., Kulinskaya E., Gough A., Norton S., Dixey J. // Rheumatology (Oxford). - 2007. - Vol.46(2). - P.350-357.

103. Maradit-Kremers H. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis. A population-based cohort study. / Maradit-Kremers H., Crowson C.S., Nicola P.J. et.al. // Arthritis Rheum. - 2005. - Vol.52(2). - P.402-411.

104. Li H.B. Risk factor assessment of cardiovascular diseases in patients with rheumatoid arthritis. / Li H.B., Bai L., Wu Q.J., Zhang X., Zhang F.C.// Zhonghua Yi Xue Za Zhi. - 2006. - Vol.86(25). - P.1769-1773.

105. Arden N.K. The increased risk of myocardial infarction in patients with rheumatoid arthritis is greatest in young women and is not due to traditional risk

factors. / Arden N.K., C.J. Edwards, D.J. Fisher, T. Van Staa, C. Cooper. // Rheumatology. - 2006. - Vol.45. -Suppl 1:i1.

106. Nicola P.J. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. / Nicola P.J., Maradit-Kremers H., Roger

V. L. et.al. // Arthritis Rheum. - 2005. - Vol.52(2). - P.412-420.

107. Crowson C.S. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? / Crowson C.S., Nicola P.J., Kremers H.M., O'Fallon

W. M., Therneau T.M., Jacobsen S.J., Roger V.L., Ballman K.V., Gabriel S.E.// Arthritis Rheum. - 2005. - Vol.52(10). - P.3039-3044.

108. Wolfe F. Increase in cardiovascular disease prevalence in rheumatoid arthritis. / Wolfe F., Freundlich B., Straus W.L. // J Rheumatol. - 2003. - Vol.30(1).

- P.36-40.

109. Hersi A.S. Obstructive sleep apnea and cardiac arrhythmias. / Hersi A.S.// Ann Thorac Med. - 2010. - Vol.5(1). - P.10-17.

110. Peters M.J. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other form of inflammatory arthritis. / Peters M.J., Symmons P.M., McCarey D. et.al. // Ann Rheum Dis.

- 2010. - Vol.69(2). - P.325-321.

111. John H. Cardiovascular co-morbidity in early rheumatoid arthritis. /John H., Kitas G., Toms T., Goodson N. // Best Pract Res Clin Rheumatol. - 2009.

- Vol.23(1). - P.71-82.

112. Davis J.M. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. /Davis J.M., Roger V.L., Crowson C.S., Kremers H.M., Therneau T.M., Gabriel S.E. // Arthritis Rheum. - 2008. - Vol.289(2). - P.194-202.

113. Goodson N.J. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. /Goodson

N.J., Marks J., Lunt M., Symmons D.// Ann Rheum Dis. - 2005. - Vol.64(11).

- P.1595-1601.

114. Schafer H. Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. /Schafer H., Koehler U., Ploch T., Peter J.H.//Chest. - 1997. - Vol.111(2). - P.387-393.

115. Young T. The gender bias in sleep apnea diagnosis. Are women missed because they have different symptoms? /Young T., Hutton R., Finn L., Badr S., Palta M.//Arch Intern Med. - 1996. - Vol.156(21). - P.2445-2451.

116. Conroy R.M. Estimation of ten-year risk of fatal cardiovascular disease in Europe:the SCORE project. /Conroy R.M., Pyorala K., Fitzgerald A.P. et.al. //Eur Heart J. - 2003. - Vol.24(11). - P.987-1003.

117. European guidelines on cardiovascular disease prevention in clinical practice:full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. - 2007. - Vol.14(2). - P.1-13.

118. Crowson C.S.Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. /Crowson C.S., Gabriel S.E.// Ann Rheum Dis. - 2011. - Vol.70(5). - P.719-721.

119. Crowson C.S. Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. /Crowson C.S., Matteson E.L., Roger V.L., Therneau T.M., Gabriel S.E. // Am J Cardiol. - 2012. - Vol.110(3).

- P.420-424.

120. Мясоедова Е.Е. Кардиоваскулярный риск у больных ревматоидным артритом. /Мясоедова Е.Е., Шостак Н.А.// Вести Ивановской медицинской академии. - 2011. -Т.16. - №4. - C.52-57.

121. Solomon D.H. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. /Solomon D.H.// Circulation. - 2003. - Vol.107(9). - P.1303-1307.

122. Silman A.J. Cigarette smoking increases the risk of rheumatoid arthritis. Result from a nationwide study of disease-disordant twins./ Silman A.J., Newman J., MacGregor A.J. // Arthritis Rheum. - 1996. - Vol. 39(5). - P.723-725.

123. Escalante A. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. /Escalante A., Hass R.W., del Rincon I.// Arch Intern Maed. - 2005. - Vol.165(14). - P.1624-1629.

124. Park Y.B. Lipid profiles in untreated patients with rheumatoid arthritis. /Park Y.B., Lee S.K., Lee W.K// J Rheumatol. - 1999. - Vol.26 (38). - P.1701-1704.

125. Innala L. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. /Innala L., Moller B., Ljung L. et.al.// Arthritis Res Ther. - 2011. - Vol.13(4). - P.131.

126. Danesh J. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. /Danesh J., Collins R., Appleby P., Peto R.// JAMA. -1998. -Vol.279(18). - P.1477-1482.

127. Kyzer S. Obstructive sleep apnea in the obese. /Kyzer S., Charuzi I.// World J Surg. - 1998. - Vol.22(9). - P.998-1001.

128. Biasucci L.M. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. /Biasucci L.M., Liuzzo G., Grillo R.L., Caligiuri G., Rebuzzi A.G., Buffon A., Summaria F., Ginnetti F., Fadda G., Maseri A. // Circulation. - 1999. - Vol.99(7). - P.855-860.

129. Marcinkowski M. Inflammatory markers 10 weeks after myocardial infarction predict future cardiovascular events. /Marcinkowski M., Czarnecka D., Jastrzebski M., Fedak D., Kawecka-Jaszcz K.// Cardiol J. - 2007. - Vol.14(1).

- P.50-58.

130. Erikssen G. Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality. /Erikssen G., Liest0l K., Bj0rnholt J.V., Stormorken H., Thaulow E., Erikssen J.// Eur Heart J. - 2000. - Vol.21(19). - P.1614-1620.

131. Goodson N.J. Coronary artery disease and rheumatoid arthritis. /Goodson N.J.// Curr Opin Rheumatol. - 2002. - Vol.14(2). - P.115-120

132. Banerjee S. Cardiovascular outcomes in male veterans with rheumatoid arthritis. /Banerjee S., Compton A.P., Hooker R.S., Cipher D.J., Reimold A., Brilakis E.S., Banerjee P., Kazi S.// Am J Cardiol. - 2008. - Vol.101(8).

- P.1201-1205.

133. Gabriel S.E. Survival in rheumatoid arthritis:a population-based analysis of trends over 40 years./ Gabriel S.E., Crowson C.S., Kremers H.M. et.al// Arthritis Rheum. - 2003. - Vol.48(1). - P.54-58.

134. Heliovaara M. Rheumatoid factor, chronic arthritis and mortality. /Heliovaara M., Aho K., Knekt P., Aromaa A., Maatela J., Reunanen A.// Ann Rheum Dis.

- 1995. - Vol.54(10). - P.811-814.

135. Wallberg-Jonsson S. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. /Wallberg-Jonsson S., Ohman M., Dahlqvist S.// J Rheumatol. - 1997. - Vol.24(3). - P.445-451.

136. Naz S.M. The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis. /Naz S.M.,

Farragher T.M., Bunn D.K., Symmons D.P., Bruce I.N.// Arthritis Rheum.

- 2008. - Vol.58(4). - P.985-989.

137. Gonzalez-Gay M.A. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. /Gonzalez-Gay M.A., Gonzalez-Juanatey C., Pineiro A., Garcia-Porrua C., Testa A., Llorca J.// J Rheumatol. - 2005. - Vol.32(7). - P.1219-1223.

138. Book C. Prediction of mortality in rheumatoid arthritis based on disease activity markers. /Book C., Saxne T., Jacobsson L.T.// J Rheumatol. - 2005.

- Vol.32(3). - P.430-434.

139. Jacobsson L.T. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians. /Jacobsson L.T., Turesson C., Hanson R.L., Pillemer S, Sievers M.L., Pettitt D.J., Bennett P.H., Knowler W.C.// Arthritis Rheum. - 2001. - Vol.44(5). - P.1170-1176.

140. Mitchell D.M. Survival, prognosis, and causes of death in rheumatoid arthritis. /Mitchell D.M., Spitz P.W., Young D.Y., Bloch D.A., McShane D.J., Fries J.F. // Arthritis Rheum. - 1986. - Vol.29(6). - P.706-714.

141. Erhardt C.C. Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study./ Erhardt C.C., Mumford P.A., Venables P.J., Maini R.N.// Ann Rheum Dis. - 1989. - Vol.48(1). - P.7-13.

142. Turesson C. Extra-articular rheumatoid arthritis: prevalence and mortality. /Turesson C., Jacobsson L., Bergstrom U.// Rheumatology (Oxford). - 1999.

- Vol.38(7). - P.668-674.

143. Turesson C. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. /Turesson C., Jarenros A., Jacobsson L.// Ann Rheum Dis. - 2004. - Vol. 63(8). - P.952-995.

144. Turesson C. Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. /Turesson C., McClelland R.L., Christianson T.J., Matteson E.L.// Ann Rheum Dis. - 2007. - Vol.66(1). - P.70-75.

145. Pincus T. Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practices./Pincus T., Keysor J., Sokka T., Krishnan E., Callahan L.F.// J Rheumatol. - 2004. - Vol.31(2). - P.229-234.

146. Nadareishvili Z. Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. /Nadareishvili Z., Michaud K., Hallenbeck J.M., Wolfe F.// Arthritis Rheum.

- 2008. - Vol.59(8). - P.1090-1096.

147. Nurmohamed M.T. The increased cardiovascular risk in rheumatoid arthritis: When does it start? /Nurmohamed M.T.// Arthritis Res Ther. - 2010.

- Vol.12(5). -P.140.

148. Ku I.A. Rheumatoid arthritis - a model of systemic inflammation driving atherosclerosis./ Ku I.A., Imboden J.B., Hsue P.Y., Ganz P. // Circ J. - 2009.

- Vol. 73. - P. 977-985.

149. Gamble G. B-mode ultrasound images of the carotid artery wall: correlation of ultrasound with histological measurements. /Gamble G., Beaumont B., Smith H., Zorn J., Sanders G., Merrilees M., MacMahon S., Sharpe N. // Atherosclerosis.

- 1993. - Vol.102(2). - P.163-173.

150. Bots M.L. Intima media thickness as a surrogate marker for generalized atherosclerosis. /Bots M.L., Grobbee D.E.// Cardiovasc Drugs Ther. - 2002.

- Vol.16(4). - P.341-351.

151. Stein J.H. American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. /Stein J.H., Korcarz C.E., Hurst R.T., Lonn E., Kendall C.B., Mohler E.R., Najjar S.S., Rembold C.M., Post W.S.// J Am Soc Echocardiogr. - 2008. - Vol.21(2). - P.93-111.

152. Coskun U. Relationship between carotid intima-media thickness and coronary angiographic findings:a prospective study. /Coskun U., Yildiz A., Esen O.B., Baskurt M., Cakar M.A., Kilickesmez K.O., Orhan L.A., Yildis S.// Cardiovasc Ultrasound. - 2009. - Vol. 31. - P.7-59.

153. Belcaro G. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1)). /Belcaro G., Nicolaides A.N., Ramaswami G., Cesarone M.R., De Sanctis M., Incandela L., Ferrari P., Geroulakos G., Barsotti A., Griffin M., Dhanjil S., Sabetai M., Bucci M., Martines G.// Atherosclerosis. - 2001. - Vol.156(2). - P.379-387.

154. Wang T.J. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. /Wang T.J., Nam B.H., Wilson P.W., Wolf P.A., Levy D., Polak J.F., D'Agostino R.B., O'Donnell C.J.// Arterioscler Thromb Vasc Biol. - 2002. - Vol.22(10). - P.1662-1667.

155. Xu M. Increased C-reactive protein associates with elevated carotid intima­media thickness in Chinese adults with normal low density lipoprotein cholesterol levels. /Xu M., Bi Y., Chen Y., Xu Y., Li M., Wang T., Wang W., Ning G.// Atheroscler Thromb. - 2013. - Vol.20(6). - P.575-584.

156. Mahajan V. Assessment of atherosclerosis by carotid intimomedial thickness in patients with rheumatoid arthritis. / Mahajan V., Handa R,. Kumar U., Sharma

S., Gulati G., Pandey R.M., Lakshmy R. // J Assoc Physicians India. - 2008.

- Vol.56. -P.587-590.

157. Targonska-Stepniak B. The relationship between carotid intima-media thickness and the activity of rheumatoid arthritis. /Targonska-Stepniak B., Drelich-Zbroja A., Majdan M.// J Clin Rheumatol. - 2011. -Vol.17(5). - P.249­255.

158. Galarza-Delgado D.A. Carotid atherosclerosis in patients with rheumatoid arthritis and rheumatoid nodules. /Galarza-Delgado D.A., Esquivel-Valerio J.A., Garza-Elizondo M.A., Gongora-Rivera F., Munoz-De Hoyos J.L., Serna-Pena G.// Reumatol Clin. - 2013. - Vol.9(3). - P.136-141.

159. del Rincon I. Effect of glucocorticoids on the arteries in rheumatoid arthritis. /del Rincon I., O'Leary D.H., Haas R.W., Escalante A.// Arthritis Rheum. - 2004.

- Vol.50(12). - P.3813-3822.

160. Kumeda Y. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. /Kumeda Y., Inaba M., Goto H., Nagata M., Henmi Y., Furumitsu Y., Ishimura E., Inui K., Yutani Y., Miki T., Shoji T., Nishizawa Y. // Arthritis Rheum. - 2002. - Vol.46(6).

- P.1489-1497.

161. del Rincon I. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. /del Rincon I., Freeman G.L., Haas R.W., O'Leary D.H., Escalante A.// Arthritis Rheum. - 2005.

- Vol.52(11). - P.3413-3423.

162. del Porto F. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. /del Porto F., Lagana B., Lai S., Nofroni I., Tinti F., Vitale M., Podesta E., Mitterhofer A.P., D'Amelio R. // Rheumatology (Oxford). - 2007.

- Vol.46(7). - P.1111-1115.

163. Ristic G.G. Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment. /Ristic G.G., Lepic T., Glisic B., Stanisavljevic D., Vojvodic D., Petronijevic M., Stefanovic D.// Rheumatology (Oxford). - 2010. - Vol.49(6). - P.1076-1081.

164. Georgiadis A.N. Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients. /Georgiadis A.N., Voulgari P.V., Argyropoulou M.I., Alamanos Y., Elisaf M., Tselepis A.D., Drosos A.A.// Semin Arthritis Rheum. - 2008. - Vol.38(1). - P.13-19.

165. Koren M.J. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. /Koren M.J., Devereux R.B., Casale P.N., Savage D.D., Laragh J.H.// Ann Intern Med. - 1991. - Vol.114(5). - P.345-352.

166. Verma A., Meris A. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. /Verma A., Meris A., Skali H., Ghali J.K., Arnold J.M., Bourgoun M., Velazquez E.J., McMurray J.J., Kober L., Pfeffer M.A., Califf R.M., Solomon S.D.// JACC Cardiovasc Imaging. - 2008. - Vol.1(5).-P.582-591

167. Pierdomenico S.D. Cardiovascular risk in subjects with left ventricular concentric remodeling at baseline examination: a meta-analysis. /Pierdomenico S.D., Di Nicola M., Pierdomenico A.M., Lapenna D., Cuccurullo F. // J Hum Hypertens. - 2011. - Vol.25(10). - P.585-591

168. di Franco M. Diastolic function abnormalities in rheumatoid arthritis. Evaluation By echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease. /di Franco M., Paradiso M., Mammarella A., Paoletti V., Labbadia G., Coppotelli L., Taccari E., Musca A.// Ann Rheum Dis. - 2000. - Vol.59(3). - P.227-229.

169. Abdul Muizz A.M. A cross-sectional study of diastolic dysfunction in rheumatoid arthritis and its association with disease activity. /Abdul Muizz A.M., Mohd Shahrir M.S., Sazliyana S., Oteh M., Shamsul A.S., Hussein H.// Int J Rheum Dis. -2011.- Vol.14(1).-P.18-30.

170. Arslan S. Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease. /Arslan S., Bozkurt E., Sari R.A., Erol M.K.// Clin Rheumatol. - 2006. - Vol.25(3). - P.294-299.

171. Yazici D. Echocardiographic evaluation of cardiac diastolic function in patients with rheumatoid arthritis: 5 years of follow-up. /Yazici D., Tokay S., Aydin S., Toprak A., Inanc N., Khan S.R., Fak A.S., Direskeneli H.// Clin Rheumatol. - 2008. - Vol.27(5). - P.647-650.

172. Alpaslan M. Doppler echocardiographic evaluation of ventricular function in patients with rheumatoid arthritis. /Alpaslan M., Onrat E., Evcik D.// Clin Rheumatol. - 2003. - Vol.22(2). - P.84-88.

173. Wislowska M. Diastolic heart function in RA patients. /Wislowska M., Jaszczyk B., Kochmanski M., Sypula S., Sztechman M. // Rheumatol Int. - 2008.

- Vol.28(6). - P.513-519.

174. Sil A. Assessment of predictive ability of Epworth scoring in screening of patients with sleep apnoea. /Sil A., Barr G.J.// Laryngol Otol. - 2012.

- Vol.126(4). - P.372-379.

175. Myasoedova E. Rheumatoid arthritis is associated with left ventricular concentric remodeling: Results of a population-based cross-sectional study. /Myasoedova E., Davis J.M., Crowson C.S., Roger V.L., Karon B.L., Borgeson D.D., Therneau T.M., Matteson E.L., Rodeheffer R.J., Gabriel S.E.// Arthritis Rheum. - 2013. - Apr 1.

176. Mirjafari H. Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study. / Mirjafari H., Farragher T.M., Verstappen S.M., Yates A., Bunn D., Marshall T., Lunt M., Symmons D.P., Bruce I.N. // Arthritis Res Ther. - 2011. - Vol.13(5). - P.159.

177. Smith S.S. Confirmatory factor analysis of the Epworth Sleepiness Scale (ESS) in patients with obstructive sleep apnoea. /Smith S.S., Oei T.P., Douglas J.A., Brown I., Jorgensen G., Andrews J.// Sleep Med. - 2008. - Vol.9(7). - P. 739-744.

178. Reading S.R. Do rheumatoid arthritis patients have a higher risk for sleep apnea? /Reading S.R., Crowson C.S., Rodeheffer R.J., Fitz-Gibbon P.D., Maradit-Kremers H., Gabriel S.E.// J Rheumatol. - 2009. - Vol. 36 (9).

- P.1869-1872.

179. Taylor-Gjevre R.M. Components of Sleep Quality and Sleep Fragmentation in Rheumatoid Arthritis and Osteoarthritis. /Taylor-Gjevre R.M., Gjevre J.A., Nair B, Skomro R., Lim H.J.// Musculoskeletal Care. - 2011. - Vol.9(3). -P.152-155.

180. Gjevre J.A. Do sleepy rheumatoid arthritis patients have a sleep disorder? /Gjevre J.A., Taylor-Gjevre R.M., Nair B.V., Lim H.J.// Musculoskeletal Care.

- 2012. - Vol.10(4). - P.187-195.

181. Ahbab S. Neck circumference. metabolic syndrome and obstructive sleep apnea syndrome; evaluation of possible linkage. /Ahbab S, Ataoglu HE, Tuna M, Karasulu L, Cetin F, Temiz LU, Yenigun M.// Med Sci Monit. - 2013.

- Vol.13(19). - P.111-117.

182. Bruce B. Health Assessment Questionnaire (HAQ) / Bruce B, Fries JF // Clin Exp Rheumatol. - 2005. - Vol.23(5 Suppl 39) - P.14-18.

183. Patil S.P. What every clinician should know about polysomnography./ Patil S.P. // Respir Care. - 2010. - Vol.55(9). -P.1179-1195.

184. Punjabi N.M. The epidemiology of adult obstructive sleep apnea. / Punjabi N.M. // Proc Am Thorac Soc. - 2008. - Vol. 15. -P. 136-143

185. Ng S.S. Validation of a portable recording device (ApneaLink) for identifying patients with suspected obstructive sleep apnoea syndrome. /Ng S.S., Chan T.O., To K.W., Ngai J., Tung A., Ko F.W., Hui D.S.// Intern Med J. - 2009. - Vol.39(11). - P.757-762.

186. Lang R.M. American Society of Echocardiography's Nomenclature and

Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. /Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J., Solomon S., Spencer K.T., St John Sutton M., Stewart W.// Eur J Echocardiogr. - 2006. - Vol.7(2). - P.79-108.

187. de Simone G. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. / de Simone G., Devereux R.B., Daniels S.R., Koren M.J., Meyer R.A., Laragh J.H.// J Am Coll Cardiol. - 1995. - Vol.25(5). - P.1056-1062.

188. Howard G. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. /Howard G., Sharrett A.R., Heiss G, Evans G.W., Chambless L.E., Riley W.A., Burke G.L.// Stroke. - 1993. - Vol.24(9). - P.1297-1304.

189. Mancia G. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of

Hypertension (ESH) and of the European Society of Cardiology (ESC). /Mancia G., De Backer G., Dominiczak A., Cifkova R. et. al.// Eur Heart J. - 2007.

- Vol.28(12). - P.1462-1536.

190. Chen H. Evaluation of a portable recording device (ApneaLink) for case selection of obstructive sleep apnea. /Chen H., Lowe A.A., Bai Y., Hamilton P., Fleetham J.A., Almeida F.R.// Sleep Breath. - 2009. - Vol.13(3). - P.213-219.

191. Myasoedova E. Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality. /Myasoedova E., Davis J.M., Crowson C.S., Gabriel S.E. // Current Rheumatology Reports. - 2010. - Vol.12(5). - P.379-385.

192. Ganau A. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. /Ganau A., Devereux R.B., Roman M.J., de Simone G., Pickering T.G., Saba P.S., Vargiu P., Simongini I., Laragh J.H. // J Am Coll Cardiol. - 1992. - Vol.19(7). - P. 1550-1558.

193. Goodson N.J. Traditional cardiovascular risk factors measured prior to the onset of inflammatory polyarthritis. /Goodson N.J., Silman A.J., Pattison D.J., Lunt M., Bunn D., Luben R., Day N., Khaw K.T., Symmons D.P.// Rheumatology (Oxford). - 2004. - Vol. 43(6). - P.731-736.

194. Chung C.P. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. /Chung C.P., Oeser A., Raggi P., Gebretsadik T., Shintani A.K., Sokka T., Pincus T., Avalos I., Stein C.M. // Arthritis Rheum. - 2005. - Vol.52(10). - P.3045-3053.

195. Dessein P.H. Independent role of conventional cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis. /Dessein P.H., Norton G.R., Woodiwiss A.J., Joffe B.I., Solomon A.// Rheumatol. - 2007.

- Vol.34(4). - P.681-688.

196. Brady S.R. The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis. / Brady S.R., de Courten B., Reid C.M., Cicuttini F.M., de Courten M.P., Liew D. // J Rheumatol. - 2009. - Vol.36(1). - P. 34-40.

197. Panoulas V.F. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. /Panoulas V.F., Douglas K.M., Milionis H.J., Stavropoulos-Kalinglou A., Nightingale P., Kita M.D., Tselios A.L., Metsios G.S., Elisaf M.S., Kitas G.D.// Rheumatology. - 2007. - Vol.46. -P.1477-1482.

198. Gabriel S.E. Why do people with rheumatoid arthritis still die prematurely? Ann Rheum Dis. - 2008. - Vol.67. - P. 30-34.

199. Рекомендации экспертов ВНОК по диагностике и лечению метаболического синдрома, второй пересмотр, 2009.

200. Wolk R. Sleep and the metabolic syndrome. / Wolk R., Somers V.K.// Exp Physiol. - 2007. - Vol.92(1). - P.67-78.

201. Calvin A.D. Obstructive sleep apnea, inflammation, and the metabolic syndrome. /Calvin A.D., Albuquerque F.N., Lopez-Jimenez F., Somers V.K.// Metab Syndr Relat Disord. - 2009. - Vol. 7(4). - P.271-278.

202. Corrales A. Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. /Corrales A., Gonzalez-Juanatey C., Peiro M.E., Blanco R., Llorca J., Gonzalez-Gay M.A.// Ann Rheum Dis. - 2014. - Vol. 73(4). - P. 722-727.

203. Veselinovic M.V. Carotid artery intima-media thickness and brachial artery flow-mediated vasodilatation in patients with rheumatoid arthritis. /Veselinovic M.V., Zivkovic V.I., Toncev S., Tasic N., Bogdanovic V., Djuric D.M., Jakovljevic V.L.J.// Vasa. - 2012. - Vol.41(5). - P.343-351.

204. Paramsothy P. Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic

Study of Atherosclerosis). /Paramsothy P., Knopp R.H., Bertoni A.G., Blumenthal R.S., Wasserman B.A., Tsai M.Y., Rue T., Wong N.D., Heckbert

S. R. // J Am Coll Cardiol. - 2010. - Vol.6(13). - P.1034-1041.

205. Skare T.L. Carotid intima-media thickness in spondyloarthritis patients. /Skare

T. L., Verceze G.C., Oliveira A.A., Perreto S. // Sao Paulo Med J. - 2013. - Vol. 131(2). - P.100-105.

206. Ребров А.П. Факторы риска сердечно-сосудистой патологии у больных ревматоидным артритом. /Ребров А.П., Никитина Н.М.// Клиническая медицина. - 2008. - №2. - C.56-59.

207. Micha R. Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. /Micha R., Imamura F., Wyler von Ballmoos. M, Solomon D.H., Hernan M.A., Ridker P.M., Mozaffarian D.// Am J Cardiol.

- 2011. - Vol. 108(9). - P.1362-1370.

208. Everett B.M. Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis. /Everett B.M., Pradhan A.D., Solomon D.H., Paynter N., Macfadyen J., Zaharris E., Gupta M., Clearfield M., Libby P., Hasan A.A., Glynn R.J., Ridker P.M.// Am Heart J. - 2013. - Vol.166(2). - P.199-207.

209. Gonzalez-Juanatey C. Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. /Gonzalez-Juanatey C., Testa A., Garcia-Castelo A., Garcia-Porrua C., Llorca J., Ollier W.E., Gonzalez-Gay M.A.// Semin Arthritis Rheum. - 2004.

- Vol.33(4). - P.231-238.

210. Baessler A. Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers - a meta-analysis. /Baessler A., Nadeem R., Harvey M., Madbouly E., Younus A., Sajid H., Naseem J., Asif A., Bawaadam H.J. // Inflamm (Lond). - 2013. - Vol.10(1). - P.13.

211. Popovic R.M. Upper airway muscle activity in normal women: influence of hormonal status. /Popovic R.M., White D.P.// J Appl Physiol. - 1998. - Vol. 84(3). - P.1055-1062.

212. Manber R. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. /Manber R., Kuo T.F., Cataldo N., Colrain I.M. // Sleep. - 2003. - Vol. 26(2). - P.163-168.

213. Wesstrom J. Sleep apnea and hormone replacement therapy: a pilot study and a literature review./ Wesstrom J., Ulfberg J., Nilsson S. // Acta Obstet Gynecol Scand. - 2005. - Vol. 84(1). - P. 54-57.

214. Carter R. Obesity and obstructive sleep apnea: or is it OSA and obesity? /Carter R., Watenpaugh D.E. // Pathophysiology. - 2008. - Vol. 15(2). - P. 71­77.

215. Pillar G. Abdominal fat and sleep apnea: the chicken or the egg? /Pillar G., Shehadeh N.// Diabetes Care. - 2008. - Vol.31. - P.303-309.

216. Kritikou I. Sleep Apnea, Sleepiness, Inflammation and Insulin Resistance in middle-aged Men and Women. /Kritikou I., Basta M., Vgontzas A.N., Pejovic S., Liao D., Tsaoussoglou M., Bixler E., Stefanakis Z., Chrousos G.// Eur Respir J.

- 2014. - Vol. 43 (1). - P.145-155.

217. Trenell M.I. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. /Trenell M.I., Ward J.A., Yee B.J., Phillips C.L., Kemp G.J., Grunstein R.R, Thompson C.H. // Diabetes Obes Metab.

- 2007. - Vol. 9(5). -P.679-687.

218. Kawaguchi Y. Different impacts of neck circumference and visceral obesity on the severity of obstructive sleep apnea syndrome. /Kawaguchi Y., Fukumoto S.,

Inaba M., Koyama H., Shoji T., Shoji S., Nishizawa Y.// Obesity (Silver Spring).

- 2011. - Vol. 19(2). - P. 276-282.

219. Usui Y. Coexistence of obstructive sleep apnoea and metabolic syndrome is independently associated with left ventricular hypertrophy and diastolic dysfunction. /Usui Y., Takata Y., Inoue Y., Shimada K., Tomiyama H., Nishihata Y., Kato K., Shiina K., Yamashina A.// Sleep Breath. - 2012. - Vol. 16(3).

- P.677-684.

220. Cioffi G. Analysis of left ventricular systolic function by midwall mechanics in patients with obstructive sleep apnoea. /Cioffi G., Russo T.E., Selmi A., Stefenelli C., Furlanello F.// Eur J Echocardiogr. - 2011. - Vol.12(1). - P.61-68.

221. Baguet J.P. Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea. /Baguet J.P., Nadra M., Barone-Rochette G., Ormezzano O., Pierre H., Pepin J.L.//Vasc Health Risk Manag. - 2009. - Vol.5. - Р.1063­1073.

222. Cloward T.V. Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. / Cloward T.V.,Walker J.M., Farney R.J., Anderson J.L.// Chest.- 2003. - Vol. 124(2). - Р.594-601.

<< |
Источник: ЦАРЁВА Елена Викторовна. КОМПЛЕКСНАЯ ОЦЕНКА КАРДИОВАСКУЛЯРНОГО РИСКА У БОЛЬНЫХ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ В СОЧЕТАНИИ С АБДОМИНАЛЬНЫМ ОЖИРЕНИЕМ И БОЛЬНЫХ РЕВМАТОИДНЫМ АРТРИТОМ. Диссертация на соискание ученой степени кандидата медицинских наук. Москва - 2014. 2014

Еще по теме Список литературы:

  1. СПИСОК ЛИТЕРАТУРЫ
  2. СПИСОК ЛИТЕРАТУРЫ
  3. Список литературы:
  4. Список литературы
  5. СПИСОК ЛИТЕРАТУРЫ
  6. СПИСОК ЛИТЕРАТУРЫ
  7. СПИСОК ЛИТЕРАТУРЫ
  8. Список литературы
  9. СПИСОК ЛИТЕРАТУРЫ:
  10. Список литературы
  11. Список литературы
  12. СПИСОК ЛИТЕРАТУРЫ
  13. СПИСОК ЛИТЕРАТУРЫ
  14. СПИСОК ЛИТЕРАТУРЫ